Gynecomastia (Male Chest) | 29. Gynecomastia surgery for special situations

Diabetes is one of the medical problems that calls for more extensive preoperative workup before gynecomastia surgery, and diabetic patients require strict blood sugar control before and after surgery because healing and infection risk matter. The operation also carries risks such as infection, bleeding, scarring, asymmetry, seroma, haematoma, possible persistent skin excess and contour deformity. Preparation may include lab testing or a medical evaluation, medication review, stopping smoking, and avoiding aspirin, anti-inflammatory drugs and herbal supplements that can increase bleeding. General health must be within tolerable limits for anaesthesia and healing, so suitability is decided individually rather than from the diagnosis alone.

Gynecomastia surgery reduces enlarged male breast tissue and can improve chest contour. When medical problems are present, more extensive preoperative workup is needed, especially with diabetes or any cardiac history; diabetic patients require strict blood sugar control. Patients must stop smoking for at least six to eight weeks before and after surgery, and weight loss is encouraged beforehand to reduce surgical risk. High blood pressure itself is not specifically addressed in these sources, so suitability depends on individual control, anaesthesia tolerance and healing capacity. General health must be within tolerable limits for anaesthesia and healing. Please discuss your medicines and blood pressure control with your doctor before surgery. This helps ensure safer anaesthesia and recovery.

Gynecomastia surgery is usually done under general anaesthetic, so heart disease matters mainly through anaesthesia safety and wound healing. The supplied surgical guidance notes that patients with medical problems require more extensive preoperative workup, especially those with diabetes or any cardiac history. Preparation may include lab testing or a medical evaluation, and current medicines may need review before surgery. Clinic policy also requires general health to be within tolerable limits for anaesthesia and healing before any operation. Therefore suitability is individual, not a simple yes or no, and should be decided after proper assessment rather than from the diagnosis alone.

Gynecomastia occurs in 10 to 40 percent of men with hyperthyroidism, although it is rarely the only symptom at presentation. Restoration of a normal thyroid state can resolve gynecomastia in one to two months. An overactive thyroid is also listed among conditions that can cause gynecomastia, and treating the underlying condition may reduce breast size. Surgery is generally considered when conservative treatments have not been effective and gynecomastia has persisted for at least six months to a year, with stable weight and general fitness for anaesthesia. Not every man with gynecomastia is a surgical candidate, so thyroid status and overall health should be assessed individually.

Gynecomastia most often results from an imbalance between estrogen and testosterone; low testosterone is among health conditions that can cause breast growth in men. For chronically low testosterone, gynecomastia may not go away without treatment. Surgery reduces breast size and may be considered when other treatments have not worked, but it is not suitable when large breasts are simply from being overweight. Evaluation may include examination, imaging, and hormone blood tests when symptoms suggest imbalance; treating an underlying condition may help. Hormone treatment may be considered before surgery in some cases. The decision depends on your health, goals, and whether the tissue is glandular or fatty.

In liver failure or cirrhosis, the liver may not metabolise estrogen normally, and alcoholic liver disease can further raise risk by disrupting testosterone synthesis and adding phytoestrogens. Cirrhosis is also listed among conditions that can cause gynecomastia. Surgery reduces enlarged breast tissue, but treating the underlying condition may help reduce breast size. Candidacy still depends on whether general health is within tolerable limits for anaesthesia and healing. Thus, liver disease is a consideration, not an automatic exclusion, and needs individual assessment. The decision should weigh possible benefits against surgical and anaesthetic risks. Medical clearance and a careful discussion of risks are important before planning surgery.

Kidney disease and dialysis are recognised causes of breast growth in men, alongside hormonal changes, medicines and other illnesses. Gynecomastia is often harmless and may not need treatment; if a medical condition is causing it, treating that condition may help reduce breast size. Surgery can reduce breast tissue when other treatments have not worked, but it is not suitable for men whose large breasts are simply due to being overweight. General health must also be within tolerable limits for anaesthesia and healing. A careful assessment of kidney status, medicines and overall fitness is therefore important before considering an operation. This is why suitability is decided individually.

Tobacco use can impair healing and increase complication risk, so sources advise stopping before surgery and during recovery. One source recommends at least four weeks before surgery and avoidance during recovery, while others recommend stopping all tobacco for at least six weeks before and six weeks after, or six to eight weeks before and after. Severe wound-healing problems and infection can occur if tobacco is used, and a surgeon may request testing and cancel surgery if use continues. Quitting smoking and other nicotine products can improve recovery and outcome. This is general guidance, not personal clearance; your surgeon will confirm timing and any required test for your case.

Being overweight can cause breast growth, and excess fat alone is not true gynecomastia. Ideal candidates should have a stable weight for at least six months, because significant fluctuations can affect results. NHS guidance says surgery is not suitable when large breasts are simply from being overweight. In Dr. Purohit's Jaipur practice, target BMI is within the normal range; slightly overweight men may still benefit without waiting, while obese or massively obese men are not operated because risk is too high and later weight loss may leave sagging skin needing further correction. General health must also be tolerable for anaesthesia and healing.

Gynecomastia may include localized fat, glandular tissue, sometimes excess skin, and can occur on one or both sides. Surgery reduces breast size; in severe cases excess skin may be reduced and areola position improved. NHS guidance says surgery is not suitable for men whose large breasts are simply from being overweight, while stable weight is an ideal candidacy factor. The procedure may use liposuction, excision, or both, depending on tissue type. General health must also be suitable for anaesthesia and healing. Candidacy depends on tissue type, weight stability and overall health. Dr. Vishal Purohit can explain relevant procedure options, suitability, benefits and limitations during consultation.

Bodybuilders are specifically affected by gynecomastia. The cause may be anabolic steroid use or hormones in over-the-counter supplements used to maintain muscle. The enlargement often persists after stopping them, and the remaining tissue can become firm over time. Persistent stromal and periductal tissue becomes fibrotic with time, and this tissue is unlikely to dissipate if longstanding. Because these men usually have little body fat, the problem is often glandular and firm. Surgery is planned according to the tissue involved; liposuction alone is less effective, so direct removal of the enlarged gland is often needed. Bodybuilders may take fish oil or steroid supplements, which are stopped before surgery to reduce bleeding risk and support healing.

Anabolic steroids can cause gynecomastia because outside testosterone suppresses natural testosterone production, allowing estrogen predominance; this may be irreversible. Surgery reduces breast size and can flatten chest contours, but if gynecomastia resulted from steroids, you must be fully free from them and maintain stable weight to maintain results. A detailed evaluation helps determine whether enlargement has a hormonal, cancer-related or unknown cause before treatment. The condition can occur at any age and may involve excess glandular tissue, fat or skin. Surgery is usually considered when conservative treatments have not been effective and expectations are realistic. Candidness about health, desires and lifestyle matters for safety.

After major weight loss, some men have minimal chest fullness that may be treated with liposuction alone, while more marked gynecomastia with chest drooping and skin redundancy extending around the back may require an upper body lift. NHS guidance also notes male breast reduction may tighten the breast area after significant weight loss that has caused skin to sag. Surgery is not suitable when large breasts are simply from being overweight, and stable weight matters because later weight loss can leave skin sagging and need further correction. The exact approach depends on remaining gland, fat and skin, and may include gland excision with tumescent liposuction; excess skin may be reduced in severe cases.

Gynecomastia can involve excess localized fat, glandular tissue and sometimes excess breast skin, so the cause matters. NHS guidance says male breast reduction may also tighten the breast area after significant weight loss that has caused skin to sag, but surgery is not suitable for men whose large breasts are simply from being overweight. Dr. Purohit's confirmed policy is to aim for a normal BMI; slightly overweight men may still benefit, while obese or massively obese men are not operated on because risk is higher and skin may sag after later weight loss, needing further correction. Before surgery, underlying medical conditions such as hormonal imbalances or medications should be evaluated and addressed.

In older men, gynecomastia may relate to age-related hormone changes, especially after 50, and sometimes to medicines, liver or kidney disease, obesity or other conditions. Gynecomastia can occur at any age, and surgery is typically recommended for older adolescents and adult men. Surgery is generally considered for persistent gynecomastia after non-surgical options have not helped, with stable weight and realistic expectations. Safety depends on overall fitness: diabetes or heart history may need more extensive preoperative workup, smoking should stop at least 6 to 8 weeks before and after surgery, and weight loss may be encouraged. Inelastic skin from age can occasionally leave excess skin, and reoperation may rarely be needed.

Loose skin is more common with age-related loss of elasticity or after major weight loss. In severe gynecomastia, excess tissue weight can stretch skin and the areola; surgery may improve areola position and size and reduce excess skin. Liposuction alone suits minimal or moderate cases with little skin excess; with lax skin, retraction is not predictable, and some authors leave skin to contract over six to eight months, while others prefer addressing excess skin at the first operation if the patient accepts scars. Extensive undermining can redistribute skin more evenly. Dr. Purohit uses tumescent liposuction, not ultrasound-assisted or power-assisted liposuction.

Gynecomastia surgery reduces male breast size and flattens chest contour; in severe cases it may also improve areola position and reduce excess skin. General surgical guidance also notes prior surgery, elevated BMI, diabetes and smoking may contribute to surgical site infections, and patients with medical problems need more extensive preoperative workup, especially diabetes or cardiac history. Smoking should stop at least six to eight weeks before and after surgery, and weight loss may be carefully encouraged preoperatively. This is a contouring procedure, not complete removal of all breast tissue and fat, and these are important general considerations rather than a personal protocol.

Gynecomastia may involve excess fat, glandular tissue, or skin. When it is mainly fatty, liposuction through small incisions may be enough. Other men need glandular tissue removed through a small semi-circular incision on the lower areola. Severe cases may also need areola or skin adjustment. Liposuction can make gland excision easier, but firm glandular tissue has limitations. After prior liposuction, revision depends on what tissue remains and how the skin has settled, so assessment is individual. The goal is a flatter, more even male chest contour, not a guaranteed identical result. A trade-off may be accepting a scar or contour limitation for a flatter chest.

Family history matters in breast surgery: one first-degree relative with breast cancer roughly doubles risk in women, and two first-degree relatives increase risk fivefold. Male breast cancer is rare, but men with enlarged breasts may have increased risk, and a first-degree male relative with breast cancer increases risk for women. Before surgery, medical history should include malignancies; if enlargement is on one side, carcinoma should be ruled out with ultrasound and/or biopsy, and ultrasound should be used before surgery in every case, while hormone blood tests are not routine. Male breast cancer can also cause a lump, so physical examination helps distinguish it from gynecomastia. Strong family history may raise questions about genetic screening.

Distinguishing glandular breast tissue from fat is part of assessment. Before surgery, patients are evaluated for underlying medical conditions that could contribute to breast enlargement, such as hormonal imbalance or certain medicines; if found, these should be addressed first. Hormonal imbalance should be treated before surgery because surgery may not be effective if the underlying problem remains. Surgery is generally considered for persistent gynecomastia lasting at least six months to a year, especially when non-surgical measures have not helped. The operation reduces breast tissue and can improve chest contour, but it is not a treatment for an unresolved hormonal cause.

Dr. Vishal Purohit requires bodybuilders using steroids or prohormones to stop completely for a minimum of 6 weeks before surgery, though 3 months is preferable. Routine pre-operative blood tests, including complete blood count and renal function tests, ensure surgical readiness. Protein supplements do not affect gynecomastia, but muscle hypertrophy can push the gland outward. Dr. Purohit performs the procedure using dual-modality circumferential liposuction and sharp gland excision through a hemi-periareolar incision along the lower areolar border. Excised tissue is sent for histopathology. Grades 1 to 3 are performed under local anaesthesia, while grade 4 requires general anaesthesia with a mandatory 24-hour observation stay.

Following massive weight loss or bariatric surgery, male chest contouring primarily targets redundant skin and severe tissue ptosis rather than isolated glandular enlargement. Significant weight reduction frequently leaves patients with extensive cutaneous laxity across the chest, axilla, and lateral torso, termed pseudogynecomastia. Studies note this loose skin substantially lowers health-related quality of life and creates functional limitations. Severe tissue ptosis often makes standard glandular excision alone inadequate to restore a flat male chest contour. As documented in surgical literature, secondary touch-up procedures or additional skin tightening may occasionally be necessary. Any combined body contouring procedures following massive weight loss are planned and priced separately.

In clinical practice, uncontrolled systemic conditions or cardiovascular problems heighten surgical risks, requiring medical stabilisation before any procedure. Underlying causes like hormonal imbalances or specific medications must be evaluated beforehand. As Dr. Vishal Purohit confirms, hormone blood tests are ordered only if other symptoms of hormonal imbalance exist, and an endocrinologist referral is made if breast development arises suddenly after puberty. While slightly overweight men can proceed without delay, obese and massively obese individuals are not operated on due to high risks and subsequent skin sagging. Furthermore, grades 1 to 3 are performed under local anaesthesia, whereas grade 4 requires general anaesthesia; sedation is never used.

Gynecomastia is characterized by excess localized fat, excess glandular tissue development, and sometimes excess breast skin, presenting either unilaterally or bilaterally. In very lean patients, visible enlargement is predominantly caused by excess glandular tissue rather than localized fat. Dr. Vishal Purohit uses a dual-modality protocol combining circumferential tumescent liposuction with sharp periareolar gland excision through an inconspicuous hemi-periareolar incision along the lower half of the areola border. In unilateral cases, this approach is applied to the affected breast to achieve symmetric contouring with the unaffected side. All excised breast tissue is routinely sent for histopathological examination.

Surgical management in his practice pairs circumferential VASER or power liposuction with sharp periareolar gland excision through an inconspicuous hemi-periareolar incision along the lower areolar border. All excised breast tissue is sent for histopathology. Grades 1 to 3 are performed under local anaesthesia, which permits same-day discharge and requires no fasting. Grade 4 requires a longer procedure under general anaesthesia with 6 hours of pre-operative fasting, mandatory 24-hour observation, and closed drains. Sedation is never used. Operative time spans 60 to 120 minutes for simpler grades and up to 4 hours for grade 4. Routine pre-operative workup includes complete blood count and renal function tests.